• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

GE HealthCare Launches AI-Powered Ultrasound for Enhanced Breast Cancer Detection in Dense Breasts

by Jasmine Pennic 03/20/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
GE HealthCare Launches AI-Powered Ultrasound for Enhanced Breast Cancer Detection in Dense Breasts

What You Should Know: 

– GE HealthCare has unveiled Invenia™ Automated Breast Ultrasound (ABUS) Premium, a cutting-edge 3D ultrasound system designed to revolutionize breast cancer screening for women with dense breast tissue. 

– The technology integrates artificial intelligence (AI) and innovative features to expedite supplemental screening, streamline exam readings, and improve detection accuracy.

AI-Driven 3D Breast Ultrasound

Dense breast tissue, present in a significant portion of women worldwide, poses a challenge for traditional mammography as it can mask cancerous tumors. With approximately 71% of cancers occurring in dense breasts, early detection is crucial. Invenia ABUS Premium addresses this issue by providing clearer, more detailed images, enhancing the sensitivity of invasive cancer detection when used in conjunction with mammography.

Invenia ABUS Premium is engineered to manage high patient volumes while delivering exceptional image quality and boosting clinical confidence. The system’s Verisound™ AI tools, featuring Scan Quality Assessment and Auto Nipple Detection, optimize exam consistency and accuracy. The new Fast Scan tool accelerates scan speed by up to 40%*, while cSound™ Imageformer capabilities ensure consistent, high-resolution image quality.

For rapid and efficient interpretation, physicians can utilize the Invenia ABUS Viewer with AI Assistant**, which leverages intelligent algorithms to assist in detecting and characterizing breast lesions. This AI-powered review can improve clinical confidence and reading efficiency, particularly in addressing staff shortages.

The ABUS Premium’s non-invasive design prioritizes patient comfort. A patient experience study indicated that 100% of women would recommend the exam to a friend. The technology’s ability to distinguish malignant tumors through specific image features has the potential to reduce unnecessary biopsies. Additionally, it eliminates patient exposure to radiation or contrast injections.

“Women with dense breasts often face poorer outcomes due to malignancies detected at later, more advanced stages. Invenia ABUS Premium equipped with AI has the potential to optimize clinicians’ screening capabilities, enabling them to detect even small, early-stage cancers with a high degree of confidence in women with dense breasts,” said Karley Yoder, CEO of Comprehensive Care Ultrasound, GE HealthCare. “Invenia ABUS Premium is designed to help deliver the best possible outcomes for patients while also prioritizing the patient experience with features to improve scan speed and enhance comfort during an exam.”  

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, Breast Cancer, GE healthcare, Ultrasound

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Bayer Exits Radiology AI Market, Discontinuing Calantic and Blackford

Oracle Health Launches AI Center of Excellence for Healthcare

Oracle Health Launches AI Center of Excellence for Healthcare

Particle Health Addresses Integration to Epic Data Despite Dispute

US Court Allows Particle’s Antitrust Claims Against Epic to Proceed

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |